Positive initial results for srRNA rabies vaccine
Drug Discovery World
FEBRUARY 19, 2024
“Achieving a broad therapeutic window is an important step-up from other existing mRNA and srRNA approaches, which allows us to expand applications of our self-replicating RNA to complex infectious diseases, off-the-shelf cancer vaccines, and as a platform for protein production.”
Let's personalize your content